OPKO Health - 30 Year Stock Price History | OPK
Historical daily share price chart and data for OPKO Health since 1995 adjusted for splits and dividends. The latest closing stock price for OPKO Health as of June 04, 2025 is 1.34.
- The all-time high OPKO Health stock closing price was 19.12 on June 03, 2015.
- The OPKO Health 52-week high stock price is 2.04, which is 52.2% above the current share price.
- The OPKO Health 52-week low stock price is 1.19, which is 11.2% below the current share price.
- The average OPKO Health stock price for the last 52 weeks is 1.50.
| OPKO Health Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 1.5340 | 1.4500 | 1.9400 | 1.2400 | 1.3450 | -8.50% |
| 2024 | 1.3315 | 1.5700 | 1.6800 | 0.8655 | 1.4700 | -2.65% |
| 2023 | 1.5303 | 1.2200 | 2.1700 | 1.0600 | 1.5100 | 20.80% |
| 2022 | 2.5910 | 4.9300 | 4.9300 | 1.0500 | 1.2500 | -74.01% |
| 2021 | 4.1099 | 4.2000 | 5.9900 | 3.3300 | 4.8100 | 21.77% |
| 2020 | 3.0656 | 1.4900 | 5.9550 | 1.1500 | 3.9500 | 168.71% |
| 2019 | 2.2225 | 3.2900 | 3.8300 | 1.4200 | 1.4700 | -51.16% |
| 2018 | 4.1101 | 4.9700 | 6.2900 | 2.4600 | 3.0100 | -38.57% |
| 2017 | 6.8777 | 9.0900 | 9.3800 | 4.6100 | 4.9000 | -47.31% |
| 2016 | 9.9056 | 10.0000 | 11.9100 | 7.6600 | 9.3000 | -7.46% |
| 2015 | 12.9449 | 9.9300 | 19.1200 | 8.4100 | 10.0500 | 0.60% |
| 2014 | 8.7105 | 8.4100 | 9.9900 | 7.5800 | 9.9900 | 18.36% |
| 2013 | 7.9517 | 5.0000 | 12.3500 | 5.0000 | 8.4400 | 75.47% |
| 2012 | 4.6262 | 4.8800 | 5.4800 | 4.0900 | 4.8100 | -1.84% |
| 2011 | 4.2107 | 3.9300 | 5.6600 | 3.2800 | 4.9000 | 33.51% |
| 2010 | 2.3495 | 1.9500 | 3.8800 | 1.6300 | 3.6700 | 100.55% |
| 2009 | 1.6652 | 1.5800 | 2.7600 | 0.6000 | 1.8300 | 12.96% |
| 2008 | 1.9220 | 2.8900 | 3.4000 | 1.0800 | 1.6200 | -43.16% |
| 2007 | 3.4997 | 0.9000 | 5.3500 | 0.9000 | 2.8500 | 235.29% |
| 2006 | 0.5875 | 0.4100 | 1.0400 | 0.3800 | 0.8500 | 107.32% |
| 2005 | 0.3964 | 0.3200 | 0.4700 | 0.3200 | 0.4100 | 20.59% |
| 2004 | 0.6663 | 0.8500 | 1.1400 | 0.3350 | 0.3400 | -62.18% |
| 2003 | 0.5510 | 0.4900 | 0.9900 | 0.3300 | 0.8990 | 156.86% |
| 2002 | 1.0923 | 3.2000 | 3.2000 | 0.3500 | 0.3500 | -89.49% |
| 2001 | 4.0984 | 7.1250 | 8.0000 | 2.2000 | 3.3300 | -54.85% |
| 2000 | 9.3660 | 7.8125 | 17.5000 | 5.0000 | 7.3750 | -1.67% |
| 1999 | 7.0873 | 7.3750 | 9.0000 | 5.4375 | 7.5000 | 9.09% |
| 1998 | 7.7846 | 7.0625 | 14.5000 | 3.2500 | 6.8750 | 0.00% |
| 1997 | 4.7328 | 2.3750 | 11.0625 | 2.3750 | 6.8750 | 223.53% |
| 1996 | 3.8822 | 4.2500 | 6.0000 | 2.0000 | 2.1250 | -50.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.094B | $0.713B |
| OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $197.793B | 86.63 |
| Thermo Fisher Scientific (TMO) | United States | $150.971B | 18.26 |
| Edwards Lifesciences (EW) | United States | $45.591B | 29.89 |
| IDEXX Laboratories (IDXX) | United States | $42.288B | 48.60 |
| Alcon (ALC) | Switzerland | $42.138B | 28.48 |
| DexCom (DXCM) | United States | $34.031B | 52.60 |
| IQVIA Holdings (IQV) | United States | $24.701B | 13.84 |
| Mettler-Toledo (MTD) | United States | $24.242B | 28.83 |
| STERIS (STE) | Ireland | $23.937B | 26.36 |
| Waters (WAT) | United States | $20.792B | 29.34 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.231B | 0.00 |
| Hologic (HOLX) | United States | $14.048B | 15.26 |
| Sysmex ADR (SSMXY) | Japan | $10.336B | 29.32 |
| Penumbra (PEN) | United States | $9.967B | 78.22 |
| Masimo (MASI) | United States | $8.883B | 32.77 |
| Globus Medical (GMED) | United States | $8.082B | 19.26 |
| Glaukos (GKOS) | United States | $5.399B | 0.00 |
| Teleflex (TFX) | United States | $5.366B | 8.86 |
| TransMedics (TMDX) | United States | $4.355B | 94.66 |
| Integer Holdings (ITGR) | United States | $4.182B | 21.91 |
| PROCEPT BioRobotics (PRCT) | United States | $3.319B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.405B | 14.32 |
| Veracyte (VCYT) | United States | $2.075B | 29.12 |
| Nihon Kohden (NHNKY) | Japan | $2.022B | 23.20 |
| Elekta AB (EKTAY) | Sweden | $1.956B | 17.59 |
| Alphatec Holdings (ATEC) | United States | $1.851B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.374B | 0.00 |
| Artivion (AORT) | United States | $1.215B | 113.80 |
| Pulse Biosciences (PLSE) | United States | $1.186B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.013B | 5.39 |
| SiBone (SIBN) | United States | $0.805B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.779B | 0.00 |
| IRadimed (IRMD) | United States | $0.760B | 38.57 |
| RxSight (RXST) | United States | $0.642B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.576B | 8.96 |
| Delcath Systems (DCTH) | United States | $0.560B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.546B | 12.80 |
| AxoGen (AXGN) | United States | $0.517B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.496B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.445B | 0.00 |
| NeuroPace (NPCE) | United States | $0.444B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.432B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.397B | 10.56 |
| Treace Medical Concepts (TMCI) | United States | $0.365B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.354B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.315B | 0.00 |
| Neuronetics (STIM) | United States | $0.254B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.239B | 14.48 |
| 908 Devices (MASS) | United States | $0.237B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.211B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.208B | 0.00 |
| CVRx (CVRX) | United States | $0.176B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.175B | 0.00 |
| Inogen (INGN) | United States | $0.172B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.171B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.163B | 0.00 |
| Accuray (ARAY) | United States | $0.162B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.161B | 0.00 |
| LENSAR (LNSR) | United States | $0.160B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.136B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.110B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.099B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.087B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.079B | 48.30 |
| InspireMD (NSPR) | United States | $0.078B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.067B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.061B | 0.00 |
| Hyperfine (HYPR) | United States | $0.058B | 0.00 |
| Positron (POSC) | United States | $0.054B | 0.00 |
| Spectral AI (MDAI) | United States | $0.044B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.043B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Envoy Medical (COCH) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.030B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.028B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.018B | 0.00 |
| NexGel (NXGL) | United States | $0.017B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.012B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.007B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.19 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |